Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant

被引:11
|
作者
Chan, Chiu Wai Shirley [1 ]
Chung, Ho Yin [1 ]
Lau, Chak Sing [1 ]
Tsang, Helen H. L. [1 ]
机构
[1] Queen Mary Hosp, Div Rheumatol & Clin Immunol, Hong Kong, Peoples R China
关键词
dermatomyositis; interstitial lung disease; MDA5; pneumomediastinum;
D O I
10.1111/1756-185X.13112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a 24-year-old man with anti-melanoma differentiation-associated gene-5 (MDA5) antibody-positive dermatomyositis (DM) and interstitial lung disease (ILD) who developed spontaneous pneumomediastinum. By comparing serial thoracic high-resolution computed tomography scans, we demonstrated the distinct time course showing a paradoxical occurrence of pneumomediastinum despite a radiological improvement of ILD. Our case shows that pneumomediastinum in DM can occur regardless of associated ILD and it is a serious complication that should be considered in DM patients presenting with pulmonary manifestations. Cutaneous vasculopathy may be associated with pneumomediastinum and could potentially be a useful indicator of future disease.
引用
收藏
页码:521 / 524
页数:4
相关论文
共 50 条
  • [31] Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies
    Ohmura, Shin-Ichiro
    Yamabe, Toru
    Naniwa, Taio
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (01) : 76 - 81
  • [32] Anti-melanoma differentiation-associated gene 5 in Chinese patients with dermatomyositis
    Li, L.
    Liu, C.
    Zhang, Y.
    Cheng, L.
    Zhang, F.
    Li, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 844 - 845
  • [33] Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
    Gui, Xianhua
    Li, Wangzhong
    Yu, Yanzhe
    Zhao, Tingting
    Jin, Ziyi
    Meng, Kaifang
    Wang, Rujia
    Shi, Shenyun
    Yu, Min
    Ma, Miao
    Chen, Lulu
    Luan, Wei
    Xin, Xiaoyan
    Qiu, Yuying
    Qiu, Xiaohua
    Zhang, Yingwei
    Cao, Min
    Cao, Mengshu
    Dai, Jinghong
    Cai, Hourong
    Huang, Mei
    Xiao, Yonglong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
    Isono, Taisuke
    Nakajima, Hiromi
    Takano, Kenji
    Kobayashi, Yoichi
    Kawabata, Yoshinori
    Shimizu, Yoshihiko
    Takayanagi, Noboru
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [35] Clinical Images: Kissing papules in anti-melanoma differentiation-associated gene 5 antibody dermatomyositis
    Alhassan, Eaman
    Wise, Leanna
    ACR OPEN RHEUMATOLOGY, 2024,
  • [36] Spontaneous Pneumomediastinum due to Anti-Melanoma Differentiation-Associated Protein 5 requiring a Bilateral Lung Transplant
    Jhajj, Amrit
    Yeung, James
    To, Fergus
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1129 - 1129
  • [37] Treating dermatomyositis anti-melanoma differentiation-associated gene 5 antibody disease. A true rheumatologic urgency
    Gardner, Gregory C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [38] Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
    He, Chenjia
    Li, Wenyu
    Xie, Qibing
    Yin, Geng
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [39] Comment on: Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis
    Matsuda, Shogo
    Kotani, Takuya
    Takeuchi, Tohru
    RHEUMATOLOGY, 2022, 61 (09) : E282 - E283
  • [40] Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease
    Romero-Bueno, F.
    Diaz del Campo, P.
    Trallero-Araguas, E.
    Ruiz-Rodriguez, J. C.
    Castellvi, I
    Rodriguez-Nieto, M. J.
    Martinez-Becerra, M. J.
    Sanchez-Pernaute, O.
    Pinal-Fernandez, I
    Solanich, X.
    Gono, T.
    Gonzalez-Gay, M. A.
    Plana, M. N.
    Selva-O'Callaghan, A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 776 - 790